Research Article
The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis
Table 2
Comorbidities in the study population.
| Comorbidities | Healthy controls | Rheumatoid patients | Premenopausal control () | Postmenopausal control () | Premenopausal patient () | Postmenopausal patient () |
| Hypertension | 2 (14.9) | 16 (47.1) | 1 (9.1) | 17 (54.8) | Arrhythmia | 2 (14.9) | 2 (5.9) | 2 (18.2) | 3 (9.7) | Hyperthyroidism | 1 (2.8) | 1 (2.9) | 1 (9.1) | / | Hashimoto thyroiditis | 1 (2.8) | 1 (2.9) | 1 (9.1) | 2 (6.5) | Hypercholesterolemia | / | 2 (5.9) | 1 (9.1) | 1 (3.2) | Gallbladder calculosis | / | / | / | 2 (6.5) | Bronchial asthma | / | / | / | 2 (6.5) | Peptic ulcer | 1 (2.8) | 2 (5.9) | / | 3 (9.7) | Gout | / | 1 (2.9) | / | / | Glaucoma | 1 (2.8) | / | / | / | Migraine | / | 1 (2.9) | / | / |
|
|
Data are presented as a number of participants (%).
|